CAG
GAB.RT

Csenge Advisory Group’s The Gabelli Equity Trust Rights (expiring April 14 2026) GAB.RT Stock Holding History

Csenge Advisory Group’s Portfolio GAB.RT Stock Details GAB.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94 Buy
+13,420
New +$134 ﹤0.01% 747

Other funds holding GAB.RT

UFM
Ursa Fund Management Danville, California $108M AUM 30.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $1.03T AUM 1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Csenge Advisory Group's GAB.RT Position: Q1 2026 in Review

Csenge Advisory Group opened a new position in The Gabelli Equity Trust Rights (expiring April 14 2026) (GAB.RT) in Q1 2026: 13,420 shares worth $94. The stake represents ﹤0.01% of the portfolio and ranks #747 among its holdings.

159 funds tracked by Wall St. Rank hold GAB.RT as of Q1 2026.

  • Csenge Advisory Group held 13,420 shares of The Gabelli Equity Trust Rights (expiring April 14 2026) worth $94 as of Q1 2026.
  • The Gabelli Equity Trust Rights (expiring April 14 2026) was a new Csenge Advisory Group position in Q1 2026.
  • The Gabelli Equity Trust Rights (expiring April 14 2026) made up ﹤0.01% of Csenge Advisory Group's portfolio in Q1 2026, its #747 holding.
  • 159 funds tracked by Wall St. Rank held The Gabelli Equity Trust Rights (expiring April 14 2026) as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.